U.S. market Closed. Opens in 2 hours 3 minutes

AYTU | Aytu BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-31
Revenue81.00M107.40M96.67M65.63M27.63M7.32M3.66M3.22M2.56M261.78K58.93K1.75K1.75KN/AN/A1.75KN/AN/A
Cost of Revenue26.42M40.77M44.39M36.43M7.55M2.20M2.05M1.42M957.08K88.11KN/A-48.25KN/AN/AN/AN/AN/AN/A
Gross Profit54.59M66.63M52.28M29.20M20.08M5.12M1.61M1.80M1.61M173.67K58.93K50.00K1.75KN/AN/A1.75KN/AN/A
Operating Expenses60.57M78.96M88.39M67.44M41.01M21.96M19.45M20.66M15.81M7.81M6.41M54.16K58.11K133.62K56.74K57.57K54.98K46.89K
Selling, General & Admin49.47M70.08M69.88M55.81M34.80M19.24M17.73M17.61M8.83M4.38M2.35M47.98K58.11K129.37K54.16K54.86K54.98K46.89K
Research & Development2.79M4.09M14.44M5.62M1.72M589.07K167.59K1.35M6.32M3.42M4.06M2.76MN/AN/AN/AN/AN/AN/A
Other Operating Expenses7.58M-4.78M4.07M6.01M4.49M2.14M6.28M1.71M664.71K4.89K6.18K6.18K7.34K4.25K2.58K2.71KN/AN/A
Operating Income-5.25M-17.07M37.22M-38.24M-20.94M-16.85M-19.70M-20.13M-21.70M-7.63M-6.35M-52.41K-56.36K-133.62K-56.74K-55.82K-54.98K-46.89K
Other Expenses / Income-8.82M14.00K1.02M840.00K7.51M-10.29M9.51M-2.38M-6.48M-114.99K-4.23K-4.90K-3.32K-3.18K-3.53K-3.07K-2.19K-2.06K
Before Tax Income-14.08M-17.05M-110.28M-58.03M-13.62M-27.13M-10.19M-22.51M-28.18M-7.75M-6.39M-57.32K-59.67K-136.80K-56.47K-58.89K-48.95K-48.95K
Income Tax Expenses1.77M-57.00K-110.00K259.00K-9.92M20.04M-2.13M1.11M8.48M-23.91K-813.70K911.30K3.32K3.18K-548.003.07K2.19K2.06K
Net Income-15.84M-17.05M-108.78M-58.29M-13.62M-47.17M-10.19M-22.51M-28.18M-7.72M-5.58M-57.32K-59.67K-136.80K-60.27K-58.89K-57.17K-48.95K
Interest Expenses4.79MN/A147.50MN/AN/AN/A749.42K2.53M5.49M114.99K45.55K4.90K3.32K3.18K3.80K3.07KN/A2.06K
Basic Shares Outstanding5.54M3.34M1.47M840.00K230.00K38.97K3.33K116.0021.0014.009.008.008.008.006.005.005.001.00
Diluted Shares Outstanding5.54M3.34M1.47M840.00K230.00K38.97K3.33K116.0021.0014.009.008.008.008.006.005.005.001.00
EBITDA-1.01M-3.51M-27.96M-29.04M-12.21M-14.12M-15.25M-18.13M-21.81M-7.51M-52.71K-47.47K-50.21K-126.86K-47.28K-47.54K-47.47K-40.47K
EBITDA Margin-1.25%-3.27%-28.92%-44.25%-44.18%-192.88%-416.75%-562.80%-851.29%-2,870.37%-89.44%-2,712.69%-2,868.91%0.00%0.00%-2,716.51%0.00%0.00%
EBIT-9.28M-17.11M38.61M-58.03M-23.54M-27.13M-11.57M-18.86M-14.20M-7.63M-6.35M858.89K-53.04K-130.44K-57.02K-52.75K-54.98K-44.83K
EBIT Margin-11.46%-15.93%39.94%-88.42%-85.19%-370.64%-316.02%-585.43%-554.33%-2,915.53%-10,770.31%49,079.49%-3,030.69%0.00%0.00%-3,014.29%0.00%0.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙